Stem Cell Therapy Could Help Stroke Patients

The Gene Therapy Advisory Committee of the United Kingdom has finally given permission to a British biotech firm to proceed with a clinical trial that will look at the efficacy of stem cell therapy in the care of stroke patients. Check Winston-Salem prp treatment.

ReNeuron requested permission from UK regulators in 2005 but was refused, so the project was transferred to the United States. The Food and Drug Administration was still hesitant to approve it, so they returned to the UK in 2008, where the Medicines and Healthcare Agency was more hopeful.

Following this final approval, the Institute of Neurological Sciences Southern General Hospital, Greater Glasgow and Clyde NHS Board will conduct the first clinical trial in April of this year.

The trial will be a partnership between a group of Scottish doctors and ReNeuron scientists. The treatment involves injecting stem cells from human foetuses into stroke patients’ brains, with the aim of repairing damaged areas and improving physical and mental function.

The aim of the first trial is to determine the therapy’s safety and viability at a variety of doses. Twelve patients will receive treatment between six and 24 months after having a stroke. They will be tracked for two years, and if the results are positive, the company will continue to refine the treatment, with an emphasis on chronically impaired people who have experienced an ischaemic stroke, which is caused by a blockage in blood flow in the brain.